Bio-Path Holdings Statistics
Want to see BPTH full AI Analyst Report?
Bio-Path Holdings (BPTH) Stock Statistics & Valuation Metrics
Total Valuation
Bio-Path Holdings has a market cap or net worth of $15.09K. The enterprise value is $1.94M.
- Market Cap
- $15.09K
- Enterprise Value
- $1.94M
Share Statistics
Bio-Path Holdings has 50,297,450 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 50,297,450
- Owned by Insiders
- ―
- Owned by Institutions
- 0.51%
Financial Efficiency
Bio-Path Holdings’s return on equity (ROE) is 1.06 and return on invested capital (ROIC) is 107.59%.
- Return on Equity (ROE)
- 1.06
- Return on Assets (ROA)
- -12.79
- Return on Invested Capital (ROIC)
- 107.59%
- Return on Capital Employed (ROCE)
- 1.02
- Revenue Per Employee
- 0
- Profits Per Employee
- -8.67M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Bio-Path Holdings is -0.00. Bio-Path Holdings’s PEG ratio is -0.00.
- PE Ratio
- -0.00
- PS Ratio
- 0.00
- PB Ratio
- -0.00
- Price to FCF
- -0.20
- Price to Operating Cash Flow
- -0.12
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Bio-Path Holdings had revenue of 0 and earned -8.67M in profits. Earnings per share was -1.10.
- Revenue
- 0
- Gross Profit
- -96.00K
- Operating Income
- -8.33M
- Pretax Income
- -8.67M
- Net Income
- -8.67M
- EBITDA
- -8.24M
- Earnings Per Share (EPS)
- -1.10
Cash Flow
In the last 12 months, operating cash flow was -77.00K and capital expenditures 0, giving a free cash flow of -77.00K billion.
- Operating Cash Flow
- -77.00K
- Free Cash Flow
- -77.00K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Bio-Path Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -510.31%
- Earnings Yield
- -45698.92%
Stock Price Statistics
- Beta
- -0.60
- 52-Week Price Change
- -68.75%
- 50-Day Moving Average
- 0.04
- 200-Day Moving Average
- 0.05
- Relative Strength Index (RSI)
- 24.47
- Average Volume (3m)
- 87.34K
Important Dates
Bio-Path Holdings upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Nov 12, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Bio-Path Holdings as a current ratio of 0.08, with Debt / Equity ratio of -5.63%
- Current Ratio
- 0.08
- Quick Ratio
- 0.08
- Debt to Market Cap
- 0.95
- Net Debt to EBITDA
- -0.06
- Interest Coverage Ratio
- -39.49
Taxes
In the past 12 months, Bio-Path Holdings has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Bio-Path Holdings EV to EBITDA ratio is -0.26, with an EV/FCF ratio of -6.92.
- EV to Sales
- 0.00
- EV to EBITDA
- -0.26
- EV to Free Cash Flow
- -6.92
- EV to Operating Cash Flow
- -6.92
Balance Sheet
Bio-Path Holdings has $2,000.00 in cash and marketable securities with $520.00K in debt, giving a net cash position of -$518.00K billion.
- Cash & Marketable Securities
- $2,000.00
- Total Debt
- $520.00K
- Net Cash
- -$518.00K
- Net Cash Per Share
- -$0.01
- Tangible Book Value Per Share
- -$0.32
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Bio-Path Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 87.92%
Scores
- Smart Score
- ―
- AI Score
- 39
